• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属氧化物和磷酸盐纳米材料与医用核素放射性标记的最新进展

Recent Advances in Metal Oxide and Phosphate Nanomaterials Radiolabeling with Medicinal Nuclides.

作者信息

Janská Tereza, Sakmár Michal, Štíbr Matěj, Vlk Martin, Kozempel Ján

机构信息

Department of Nuclear Chemistry, Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Břehová 7, 11519 Prague 1, Czech Republic.

出版信息

ACS Omega. 2024 Sep 12;9(38):39297-39306. doi: 10.1021/acsomega.4c04145. eCollection 2024 Sep 24.

DOI:10.1021/acsomega.4c04145
PMID:39346817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11425600/
Abstract

The utilization of nanomaterials in biomedical applications has surged in recent years; yet, the transition from research to practical implementation remains a great challenge. However, a promising area of research has emerged with the integration of nanomaterials with diagnostic and therapeutic radionuclides. In this Review, we elucidate the motivations behind selecting metal oxide- and phosphate-based nanomaterials in conjunction with these radionuclides, while addressing its issues and limitations. Various metal oxide- and phosphate-based nanoparticles, exhibiting low toxicity and high tolerability, have been proposed for diverse biomedical applications, ranging from bone substitutes to drug delivery systems and controlled release vectors for pharmaceuticals, including radionuclides for nuclear medicine imaging and therapy. Moreover, the potential synergistic effects of multimodal combinational therapies, integrating chemotherapeutics, immunomodulators, or hyperthermia, underscore the versatility of these nanoconstructs. Our comprehensive exploration includes the underlying principles of radiolabeling strategies, the pivotal attributes of nanomaterial platforms, and their applications. Through this perspective, we present the potential of nanotechnology-enabled nuclear medicine. Furthermore, we discuss the potential systemic and local applications of these nanoconstructs, considering their and characteristics, as well as their physicochemical properties.

摘要

近年来,纳米材料在生物医学应用中的使用量激增;然而,从研究到实际应用的转变仍然是一个巨大的挑战。不过,随着纳米材料与诊断和治疗用放射性核素的结合,一个很有前景的研究领域已经出现。在这篇综述中,我们阐明了选择金属氧化物基和磷酸盐基纳米材料与这些放射性核素结合的背后动机,同时探讨了其问题和局限性。各种金属氧化物基和磷酸盐基纳米颗粒具有低毒性和高耐受性,已被提议用于多种生物医学应用,从骨替代物到药物递送系统以及药物(包括用于核医学成像和治疗的放射性核素)的控释载体。此外,整合化疗药物、免疫调节剂或热疗的多模态联合疗法的潜在协同效应,凸显了这些纳米结构的多功能性。我们的全面探索包括放射性标记策略的基本原理、纳米材料平台的关键属性及其应用。通过这个视角,我们展示了纳米技术支持的核医学的潜力。此外,我们讨论了这些纳米结构的潜在全身和局部应用,考虑到它们的……特性以及它们的物理化学性质。 (注:原文中“considering their and characteristics”部分内容缺失)

相似文献

1
Recent Advances in Metal Oxide and Phosphate Nanomaterials Radiolabeling with Medicinal Nuclides.金属氧化物和磷酸盐纳米材料与医用核素放射性标记的最新进展
ACS Omega. 2024 Sep 12;9(38):39297-39306. doi: 10.1021/acsomega.4c04145. eCollection 2024 Sep 24.
2
An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.纳米尺度放射性核素和放射性标记纳米材料概述,通常用于核分子成像和治疗功能。
J Biomed Mater Res A. 2019 Jan;107(1):251-285. doi: 10.1002/jbm.a.36550. Epub 2018 Oct 25.
3
Metal Oxide Nanoparticles as Biomedical Materials.金属氧化物纳米颗粒作为生物医学材料
Biomimetics (Basel). 2020 Jun 8;5(2):27. doi: 10.3390/biomimetics5020027.
4
Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.通过配位化学对基于二氧化硅的纳米粒子进行放射性标记:基本原理、策略及应用。
Acc Chem Res. 2018 Mar 20;51(3):778-788. doi: 10.1021/acs.accounts.7b00635. Epub 2018 Feb 28.
5
Potential Biomedical Applications of Terbium-Based Nanoparticles (TbNPs): A Review on Recent Advancement.基于铽的纳米粒子(TbNPs)的潜在生物医学应用:近期进展综述。
ACS Biomater Sci Eng. 2024 May 13;10(5):2703-2724. doi: 10.1021/acsbiomaterials.3c01969. Epub 2024 Apr 22.
6
Radiolabeling nanomaterials for multimodality imaging: New insights into nuclear medicine and cancer diagnosis.用于多模态成像的放射性标记纳米材料:核医学与癌症诊断的新见解
Biomaterials. 2020 Jan;228:119553. doi: 10.1016/j.biomaterials.2019.119553. Epub 2019 Oct 22.
7
New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles.氧化铁纳米颗粒生物医学应用的新视角
Curr Med Chem. 2018 Feb 12;25(4):540-555. doi: 10.2174/0929867324666170616102922.
8
Metal-Organic Framework Derived Nanozymes in Biomedicine.金属有机框架衍生纳米酶在生物医学中的应用。
Acc Chem Res. 2020 Jul 21;53(7):1389-1400. doi: 10.1021/acs.accounts.0c00268. Epub 2020 Jun 29.
9
Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics.基于金属的纳米诊疗剂的放射性标记策略和药代动力学研究。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Mar;13(2):e1671. doi: 10.1002/wnan.1671. Epub 2020 Oct 12.
10
Using Nanomaterials as Excellent Immobilisation Layer for Biosensor Design.利用纳米材料作为生物传感器设计的优异固定化层。
Biosensors (Basel). 2023 Jan 27;13(2):192. doi: 10.3390/bios13020192.

本文引用的文献

1
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.用于癌症治疗的放射纳米药物:一段科学历程与前景展望
EJNMMI Radiopharm Chem. 2024 May 4;9(1):37. doi: 10.1186/s41181-024-00266-y.
2
Biodistribution study of Pb progeny released from intravenously applied Ra labelled TiO nanoparticles in a mouse model.静脉注射放射性标记 TiO2 纳米颗粒后体内 Pb 产物的生物分布研究。
Nucl Med Biol. 2024 Mar-Apr;130-131:108890. doi: 10.1016/j.nucmedbio.2024.108890. Epub 2024 Feb 19.
3
Synthesis, Characterization, and Therapeutic Efficacy of Lu-DMSA@SPIONs in Nanobrachytherapy of Solid Tumors.镥-二巯基丁二酸@超顺磁性氧化铁纳米粒子在实体瘤近距离治疗中的合成、表征及治疗效果
Pharmaceutics. 2023 Jul 13;15(7):1943. doi: 10.3390/pharmaceutics15071943.
4
Iron oxide nanoparticles as positive T contrast agents for low-field magnetic resonance imaging at 64 mT.氧化铁纳米颗粒作为正 T 对比剂在 64mT 低场磁共振成像中的应用。
Sci Rep. 2023 Jul 17;13(1):11520. doi: 10.1038/s41598-023-38222-6.
5
Approved Nanomedicine against Diseases.已批准的用于治疗疾病的纳米药物。
Pharmaceutics. 2023 Feb 26;15(3):774. doi: 10.3390/pharmaceutics15030774.
6
Inorganic Nanomaterials Used in Anti-Cancer Therapies:Further Developments.用于抗癌治疗的无机纳米材料:进一步发展
Nanomaterials (Basel). 2023 Mar 22;13(6):1130. doi: 10.3390/nano13061130.
7
Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts.用于癌症诊断与治疗的放射性标记纳米材料:原理与概念
Cancer Nanotechnol. 2023;14(1):15. doi: 10.1186/s12645-023-00165-y. Epub 2023 Feb 27.
8
Nano-hydroxyapatite radiolabeled with radium dichloride [Ra] RaCl for bone cancer targeted alpha therapy: In vitro assay and radiation effect on the nanostructure.用二氯化镭[Ra] RaCl放射性标记的纳米羟基磷灰石用于骨癌靶向α治疗:体外测定及对纳米结构的辐射效应
Colloids Surf B Biointerfaces. 2023 Mar;223:113174. doi: 10.1016/j.colsurfb.2023.113174. Epub 2023 Jan 26.
9
Design and evaluation of P-labeled hydroxyapatite nanoparticles for bone tumor therapy.用于骨肿瘤治疗的 P 标记羟基磷灰石纳米粒子的设计与评价。
Drug Deliv. 2023 Dec;30(1):2168791. doi: 10.1080/10717544.2023.2168791.
10
Study of Bi and Pb Recoils Release from Ra Labelled TiO Nanoparticles.镭标记的二氧化钛纳米颗粒中铋和铅反冲释放的研究。
Materials (Basel). 2022 Dec 30;16(1):343. doi: 10.3390/ma16010343.